Successful Surgical Treatment of a Recurrent Pelvic Solitary Fibrous Tumor of Uterine Origin Accompanied by Doege-Potter Syndrome: A Case Report

Yasunori Deguchi; Wataru Komuta; Tomokazu Watanabe; Kazuho Saiga; Koki Kurahashi; Kazuo Otsuka; Koji Hirata; Masaki Mizumoto; Akihiro Kitaoka; Masazumi Zaima

doi:10.12659/AJCR.936806

13 October 2022 : Case report Japan

Successful Surgical Treatment of a Recurrent Pelvic Solitary Fibrous Tumor of Uterine Origin Accompanied by Doege-Potter Syndrome: A Case Report

Mistake in diagnosis, Rare disease

Yasunori Deguchi^1ABCDEF*, Wataru Komuta^1BCDEF, Tomokazu Watanabe^2BCD, Kazuho Saiga^3BCD, Koki Kurahashi^1B, Kazuo Otsuka^1B, Koji Hirata^1B, Masaki Mizumoto^1B, Akihiro Kitaoka^1B, Masazumi Zaima^1ABE

DOI: 10.12659/AJCR.936806

Am J Case Rep 2022; 23:e936806

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 5. Immunoblotting of IGF-II for perioperative serum and resected specimen. The dense band at around 15 kDa (high-molecular-weight IGFII) in the patient’s preoperative serum (lane 1) disappeared in the patient’s postoperative serum (lane 2). The homogenized tumor tissue also had an IGF-II band (lane 3). NC – negative control; PC – positive control; ST – standard of this IGF-II antibody (7 kDa).

Back to the Article

Successful Surgical Treatment of a Recurrent Pelvic Solitary Fibrous Tumor of Uterine Origin Accompanied by Doege-Potter Syndrome: A Case Report

Your Privacy